Sonodynamic Therapy With Concentric Ultrasound Imaging Array for Precision Theranostics for Atherosclerotic Plaque
- 21 October 2022
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
- Vol. 69 (12) , 3270-3283
Abstract
Atherosclerotic cardiovascular disease is a major cause of human disability and mortality. Our previous study demonstrated the safety and efficacy of sonodynamic therapy (SDT) on atherosclerotic plaques. However, traditional single-element therapeutic transducer has single acoustic field, and positioning therapeutic and imaging transducers in the same position is difficult during ultrasound imaging-guided SDT. Continuously changing the position of transducers to intervene lesions in different positions is required, increasing the difficulty of treatment. Thus, SDT device with precise theranostics is required. Therefore, we designed and fabricated a ’concentric ultrasound transducer for theranostics’ (CUST-T), comprising a central 8 MHz linear array transducer for ultrasound imaging, and a peripheral 1 MHz hollow two-dimensional planar array transducer for generating phased-array focused ultrasound (PAFUS). The CUST-T exhibited high imaging resolution at a distance of up to 20 mm from the transducer and could generate personalized complex PAFUS acoustic field to match various lesions. In vitro biomedical results showed that, PAFUS-SDT induced RAW264.7-derived foam cell apoptosis leading to a targeting field apoptotic rate 4.36 to 6.24-times that of the non-targeting field and the significant apoptotic region was consistent with PAFUS acoustic field. In vivo , PAFUS-SDT guided by ultrasound imaging significantly increased the lumen area (P < 0.05) and collagen level (P < 0.01), whereas the wall thickness (P < 0.05) and lipid content (P < 0.01) of rabbit femoral artery were reduced. In conclusion, CUST-T provided image guidance sufficient for accurate SDT for atherosclerotic plaques in peripheral arteries and could be applied in clinical practice.Keywords
Funding Information
- National Natural Science Foundation of China through the Major Research Equipment Development Project (81727809)
- National Natural Science Foundation of China through the State Key Project (81530052)
This publication has 43 references indexed in Scilit:
- The decomposition of protoporphyrin IX by ultrasound is dependent on the generation of hydroxyl radicalsUltrasonics Sonochemistry, 2015
- Real-time detection of intracellular reactive oxygen species and mitochondrial membrane potential in THP-1 macrophages during ultrasonic irradiation for optimal sonodynamic therapyUltrasonics Sonochemistry, 2015
- The chemotaxis of M1 and M2 macrophages is regulated by different chemokinesJournal of Leukocyte Biology, 2014
- Ultrafast imaging in biomedical ultrasoundIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 2014
- The Predominant Pathway of Apoptosis in THP-1 Macrophage-Derived Foam Cells Induced by 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy is the Mitochondria-Caspase Pathway Despite the Participation of Endoplasmic Reticulum StressCellular Physiology and Biochemistry, 2014
- Ultrasound-guided compression repair of peripheral artery pseudoaneurysm: 8 years' experience of a single instituteJournal of the Chinese Medical Association, 2012
- Hematoporphyrin monomethyl ether-mediated photodynamic effects on THP-1 cell-derived macrophagesJournal of Photochemistry and Photobiology B: Biology, 2010
- Adaptive HIFU noise cancellation for simultaneous therapy and imaging using an integrated HIFU/imaging transducerPhysics in Medicine & Biology, 2010
- Pathogenesis of AtherosclerosisJACC, 2006
- Food and Drug Administration ultrasound device regulation: The output display standard, the “mechanical index,” and ultrasound safetyJournal of the American Society of Echocardiography, 1996